The Genomics Biomarker Market was valued at USD 4.84 billion in 2023 and is projected to reach USD 10.39 billion by 2032, registering a CAGR of 8.89% over the forecast period from 2024 to 2032. The market's expansion is fueled by the rising prevalence of chronic diseases, increasing adoption of personalized medicine, and advancements in genomic sequencing...